These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 8282546)

  • 1. American business ethics and health care costs.
    Garrett TM; Klonoski RJ; Baillie HW
    Health Care Manage Rev; 1993; 18(4):44-50. PubMed ID: 8282546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In the market for ethics. Marketing begins with values.
    Schick IC; Schick TA
    Health Prog; 1989 Oct; 70(8):72-6. PubMed ID: 10303927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical misconduct in healthcare financial management.
    Sandrick KM
    Hosp Financ Manage; 1993 Mar; 47(3):35-40, 42. PubMed ID: 11660171
    [No Abstract]   [Full Text] [Related]  

  • 4. Deception in advertising and marketing: ethical applications in rehabilitation.
    Banja JD
    Arch Phys Med Rehabil; 1994 Sep; 75(9):1015-8. PubMed ID: 8085923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covenant model of corporate compliance. "Corporate integrity" program meets mission, not just legal, requirements.
    Tuohey JF
    Health Prog; 1998; 79(4):70-5. PubMed ID: 10181597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the business of medicine: models for integrating ethics and managed care.
    Regan AC
    Columbia J Law Soc Probl; 1997; 30(4):635-84. PubMed ID: 11660772
    [No Abstract]   [Full Text] [Related]  

  • 8. Catholic health care: partnering and progress.
    Byron WJ
    America (NY); 1996 Sep; 175(8):16-21. PubMed ID: 11660277
    [No Abstract]   [Full Text] [Related]  

  • 9. Can HMOs wield market power? Assessing antitrust liability in the imperfect market for health care financing.
    Glassman ML
    Am Univ Law Rev; 1996 Oct; 46(1):91-147. PubMed ID: 10169685
    [No Abstract]   [Full Text] [Related]  

  • 10. Bringing market medicine to professional account.
    Emanuel L
    JAMA; 1997 Mar; 277(12):1004-5. PubMed ID: 9091652
    [No Abstract]   [Full Text] [Related]  

  • 11. The market ethos and the integrity of health care.
    Dell'Oro R
    J Contemp Health Law Policy; 2002; 18(3):641-7. PubMed ID: 12491660
    [No Abstract]   [Full Text] [Related]  

  • 12. Market power, collusion, and exclusion in health care antitrust enforcement.
    Spears JM
    J Med Assoc Ga; 1992 Sep; 81(9):499-507. PubMed ID: 1402429
    [No Abstract]   [Full Text] [Related]  

  • 13. Competition and antitrust enforcement in the changing pharmaceutical marketplace.
    Whitener MD
    Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998
    [No Abstract]   [Full Text] [Related]  

  • 14. Business espionage: a trend coming to health care?
    Summers J
    J Healthc Mater Manage; 1993 Oct; 11(9):54-5. PubMed ID: 10129229
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals and medical devices: business practices. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-44. PubMed ID: 21374840
    [No Abstract]   [Full Text] [Related]  

  • 16. Ethics czar aims to heal Columbia.
    Pasztor A; Lagnado L
    Wall St J (East Ed); 1997 Nov; ():B1, B6. PubMed ID: 11647530
    [No Abstract]   [Full Text] [Related]  

  • 17. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical and legal remedies to over-utilization of health care resources.
    Verdirame KM
    Creighton Law Rev; 1992 Jun; 25(4):1537-80. PubMed ID: 11654462
    [No Abstract]   [Full Text] [Related]  

  • 19. What's wrong with home care? An administrative ethics perspective.
    Salvatore T; Baxter T
    J Ethics Law Aging; 1998; 4(2):69-78. PubMed ID: 11657721
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing fraud and abuse fallout.
    Mayer CM
    Healthc Financ Manage; 1995 Apr; 49(4):40, 42, 44 passim. PubMed ID: 10146166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.